Estrogen receptor-α expression in neuronal cells affects bone mass

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 3, 2012, Pages 983-988

  Ohlsson, Claes ^a   Engdahl, Cecilia ^a   Börjesson, Anna E ^a   Windahl, Sara H ^a   Studer, Erik ^a   Westberg, Lars ^a   Eriksson, Elias ^a   Koskela, Antti ^b   Tuukkanen, Juha ^b   Krust, Andree ^c   Chambon, Pierre ^c   Carlsten, Hans ^a   Lagerquist, Marie K ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; LEPTIN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; BONE STRENGTH; CONTROLLED STUDY; CORTICAL BONE; FEMALE; FEMUR; HYPOTHALAMUS; IN VIVO STUDY; JOINT STIFFNESS; MALE; MOUSE; NERVE CELL; NERVOUS TISSUE; NONHUMAN; OSSIFICATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; TRABECULAR BONE; WHITE ADIPOSE TISSUE;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE REMODELING; ESTROGEN RECEPTOR ALPHA; FEMALE; FOLLICLE STIMULATING HORMONE; GENE DELETION; INTERMEDIATE FILAMENT PROTEINS; LEPTIN; LUTEINIZING HORMONE; MICE; NERVE TISSUE PROTEINS; NEURONS; ORGAN SIZE; OVARIECTOMY; SEROTONIN; SIGNAL TRANSDUCTION; STEROIDS; T-LYMPHOCYTES;

MUS;

EID: 84856402590     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1111436109     Document Type: Article

References (51)

1. Gajda M, Litwin JA, Cichocki T, Timmermans JP, Adriaensen D (2005) Development of sensory innervation in rat tibia: Co-localization of CGRP and substance P with growth-associated protein 43 (GAP-43). J Anat 207:135-144. (Pubitemid 41102908)
2. Ducy P, et al. (2000) Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 100:197-207. (Pubitemid 30064908)
3. Elefteriou F, et al. (2005) Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434:514-520. (Pubitemid 40477060)
4. Takeda S, Karsenty G (2008) Molecular bases of the sympathetic regulation of bone mass. Bone 42:837-840.
5. Cirmanová V, Bayer M, Stárka L, Zajícková K (2008) The effect of leptin on bone: An evolving concept of action. Physiol Res 57(Suppl 1):S143-S151.
6. Sienkiewicz E, et al. (2011) Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women. Metabolism 60:1211-1221.
7. Yadav VK, et al. (2009) A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 138:976-989.
8. Yadav VK, et al. (2008) Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135:825-837.
9. Cui Y, et al. (2011) Lrp5 functions in bone to regulate bone mass. Nat Med 17: 684-691.
10. Lacey DL, et al. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176. (Pubitemid 28180851)
11. Vanderschueren D, et al. (2004) Androgens and bone. Endocr Rev 25:389-425. (Pubitemid 38786452)
12. Riggs BL, Khosla S, Melton, LJ, 3rd (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279-302. (Pubitemid 34651948)
13. Vandenput L, Ohlsson C (2009) Estrogens as regulators of bone health in men. Nat Rev Endocrinol 5:437-443.
14. Lindberg MK, et al. (2002) Estrogen receptor specificity for the effects of estrogen in ovariectomized mice. J Endocrinol 174:167-178. (Pubitemid 34965757)
15. Turner RT (1999) Mice, estrogen, and postmenopausal osteoporosis. J Bone Miner Res 14:187-191.
16. Börjesson AE, et al. (2011) Roles of transactivating functions 1 and 2 of estrogen receptor-alpha in bone. Proc Natl Acad Sci USA 108:6288-6293.
17. Sims NA, et al. (2003) A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice. J Clin Invest 111:1319-1327. (Pubitemid 36554702)
18. Lindberg MK, et al. (2003) Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice. Mol Endocrinol 17:203-208. (Pubitemid 36187395)
19. Takano-Yamamoto T, Rodan GA (1990) Direct effects of 17 beta-estradiol on trabecular bone in ovariectomized rats. Proc Natl Acad Sci USA 87:2172-2176.
20. Sjögren K, et al. (2009) Elevated aromatase expression in osteoblasts leads to increased bone mass without systemic adverse effects. J Bone Miner Res 24:1263-1270.
21. Nakamura T, et al. (2007) Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130:811-823. (Pubitemid 47332572)
22. Gillies GE, McArthur S (2010) Estrogen actions in the brain and the basis for differential action in men and women: A case for sex-specific medicines. Pharmacol Rev 62: 155-198.
23. Andersson N, et al. (2005) Investigation of central versus peripheral effects of estradiol in ovariectomized mice. J Endocrinol 187:303-309. (Pubitemid 41685190)
24. Lindberg MK, et al. (2001) Estrogen receptor specificity in the regulation of the skeleton in female mice. J Endocrinol 171:229-236. (Pubitemid 33061699)
25. Morris DL, Rui L (2009) Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab 297:E1247-E1259.
26. Dienz O, Rincon M (2009) The effects of IL-6 on CD4 T cell responses. Clin Immunol 130:27-33.
27. Tronche F, et al. (1999) Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 23:99-103. (Pubitemid 29418797)
28. Wintermantel TM, et al. (2006) Definition of estrogen receptor pathway critical for estrogen positive feedback to gonadotropin-releasing hormone neurons and fertility. Neuron 52:271-280. (Pubitemid 44548337)
29. Martin-MillanM, et al. (2010) The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol Endocrinol 24: 323-334.
30. NomuraM, et al. (2005) Differential distribution of estrogen receptor (ER)-alpha and ERbeta in the midbrain raphe nuclei and periaqueductal gray in male mouse: Predominant role of ER-beta in midbrain serotonergic systems. Neuroscience 130:445-456. (Pubitemid 40125483)
31. Cornish J, et al. (2002) Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 175:405-415. (Pubitemid 35414387)
32. Thomas T, et al. (1999) Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140:1630-1638. (Pubitemid 29149231)
33. Williams GA, et al. (2011) Skeletal phenotype of the leptin receptor-deficient db/db mouse. J Bone Miner Res 26:1698-1709.
34. Frederich RC, et al. (1995) Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nat Med 1:1311-1314.
35. Shughrue PJ, Lane MV, Merchenthaler I (1997) Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol 388: 507-525. (Pubitemid 27481288)
36. Del Bianco-Borges B, Cabral FJ, Franci CR (2010) Co-expression of leptin and oestrogen receptors in the preoptic-hypothalamic area. J Neuroendocrinol 22:996-1003.
37. Bennett PA, et al. (1999) Cyclical variations in the abundance of leptin receptors, but not in circulating leptin, correlate with NPY expression during the oestrous cycle. Neuroendocrinology 69:417-423. (Pubitemid 29273907)
38. Ainslie DA, et al. (2001) Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y. Int J Obes Relat Metab Disord 25:1680-1688. (Pubitemid 33052080)
39. Brown LM, Gent L, Davis K, Clegg DJ (2010) Metabolic impact of sex hormones on obesity. Brain Res 1350:77-85.
40. Kong YY, et al. (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304-309.
41. Cenci S, et al. (2003) Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci USA 100:10405-10410. (Pubitemid 37071891)
42. Palmqvist P, Persson E, Conaway HH, Lerner UH (2002) IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. J Immunol 169:3353-3362. (Pubitemid 35013185)
43. Daly E, et al. (1996) Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 348:977-980. (Pubitemid 26340751)
44. Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350:1047-1059.
45. Dupont S, et al. (2000) Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 127:4277-4291.
46. van Casteren JI, Schoonen WG, Kloosterboer HJ (2000) Development of time-resolved immunofluorometric assays for rat follicle-stimulating hormone and luteinizing hormone and application on sera of cycling rats. Biol Reprod 62:886-894. (Pubitemid 30173801)
47. Windahl SH, Vidal O, Andersson G, Gustafsson JA, Ohlsson C (1999) Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. J Clin Invest 104:895-901. (Pubitemid 29536339)
48. Movérare S, et al. (2003) Differential effects on bone of estrogen receptor alpha and androgen receptor activation in orchidectomized adult male mice. Proc Natl Acad Sci USA 100:13573-13578. (Pubitemid 37448563)
49. Eriksen T, Koch R, Nautrup CP (1994) Microradiography of the feline marginal periodontium with a microfocal high-resolution X-ray system. Scand J Dent Res 102:284-289.
50. Parfitt AM, et al.; Report of the ASBMR Histomorphometry Nomenclature Committee (1987) Bone histomorphometry: Standardization of nomenclature, symbols, and units. J Bone Miner Res 2:595-610.
51. Islander U, et al. (2003) Influence of oestrogen receptor alpha and beta on the immune system in aged female mice. Immunology 110:149-157. (Pubitemid 37059683)